Point72 Asset Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $905K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.03M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $11.6K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $31M | Sell |
|
|||||
|
2022
Q2 | $24.2M | Sell |
|
|||||
|
2022
Q1 | $35.4M | Buy |
|
|||||
|
2021
Q4 | $21.3M | Buy |
|
|||||
|
2021
Q3 | $5.77M | Buy |
|
|||||
|
2021
Q2 | $6.23M | Buy |
|
|||||
|
2021
Q1 | $6.07M | Sell |
|
|||||
|
2020
Q4 | $9.14M | Buy |
|
|||||
|
2020
Q3 | $7.5M | Buy |
|
|||||
|
2020
Q2 | $7.36M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $5.34M | Buy |
|